Crinetics Pharmaceuticals
CRNXCrinetics Pharmaceuticals is a commercial-stage biopharmaceutical company specializing in the discovery and development of novel small molecule therapeutics for endocrine diseases and endocrine-related tumors.
Earnings
Next report
Aug 4, 2026 (In 6 days)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
By net margin
Profile
Crinetics Pharmaceuticals is a commercial-stage biopharmaceutical company specializing in the discovery and development of novel small molecule therapeutics for endocrine diseases and endocrine-related tumors. The company leverages a proprietary platform to target G protein-coupled receptors (GPCRs) with orally available treatments designed to replace traditional injectable therapies. Their core value proposition lies in improving patient quality of life through biochemical control and treatment convenience.
A pioneer in oral GPCR-targeted endocrine therapies, transitioning from a clinical-stage R&D firm to a commercial-stage organization with a first-in-class oral treatment for acromegaly.
Questions, answered.
- What is Crinetics Pharmaceuticals's market cap?
- Crinetics Pharmaceuticals (CRNX) has a market capitalization of $8.9B and trades on NASDAQ.
- What is Crinetics Pharmaceuticals's revenue and profitability?
- Crinetics Pharmaceuticals generated $18.1M in trailing twelve-month revenue with a net loss of $496.4M, representing a net margin of -2747.2%. Gross margin stands at 150.0%, with free cash flow of -$419.5M. These figures are based on the Q1 2026 filing.
- Who are Crinetics Pharmaceuticals's competitors?
- Crinetics Pharmaceuticals's key competitors include Neurocrine Biosciences, Corcept Therapeutics Inc., Xeris Biopharma Holdings, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
- Who does Crinetics Pharmaceuticals partner with?
- Crinetics Pharmaceuticals's notable partners include Sanwa Kagaku Kenkyusho Co., Ltd., Ipsen, Novartis.
- Where is Crinetics Pharmaceuticals headquartered?
- Crinetics Pharmaceuticals is headquartered in United States of America and employs approximately 210 people. It has been publicly traded since 2018.
